Navin Fluorine Q3 Results: Navin Fluorine International announced its results for the quarter ending December 2025 (Q3FY26) on February 2. The company posted a strong set of financial numbers, posting ...

WASHINGTON, DC – The Center for Strategic and International Studies (CSIS), a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...

Pawan Kalyan, fresh off the success of 'They Call Him OG', is gearing up for his next venture with director Surender Reddy. This project, a reunion of a previously planned film, is reportedly set to ...

Citi maintained a sell rating and raised its target price to Rs 5,550 from Rs 4,900. It noted that EBITDA rose 110 per cent year-on-year and margins improved sharply, but said the stock’s recent rally ...

Feb 18 (Reuters) - India's Stable Money has raised $25 million in a round led by Peak XV Partners, as the fixed-income investment platform aims to triple its assets under management by year-end to 150 ...

Shares of Navin Fluorine International slipped on Tuesday after the chemicals major reported earnings for the third quarter of FY26, which more than doubled year on year. At 12:38 pm, Navin Fluorine ...

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active ...

Capacity for Chemours product line to get operational in Q1 FY27 ...